勵晶太平洋(00575.HK)擬379萬美元收購DLI全部股權進軍保健養生領域
格隆匯9月2日丨勵晶太平洋(00575.HK)公告,於2020年9月2日,公司與Deep Longevity, Inc.的全體股東及DLI ESOP獲獎勵人士訂立具有法律約束力的購股協議,內容有關公司就DLI已發行及流通在外股份以及DLI ESOP獎勵進行的有條件收購事項,代價約379萬美元透過發行代價股份償付。
購股協議規定須就收購事項發行約4.23億股代價股份,相當於公司經配發及發行代價股份而擴大已發行股本約18.70%。交易完成後,DLI將成為公司全資附屬公司。
DLI現正開發可解釋及容易使用的人工智能系統,以追蹤分子、細胞、組織、器官、系統、生理及心理水平的老化率。DLI亦着手為長壽醫學的新興領域開發系統,讓醫生得以針對減慢或逆轉老化過程之應對措施作出更理想決策。DLI已開發Longevityasa Service (LaaS)解決方案,結合多個被稱為深層老化時鐘的深層生物指標,從而提供衡量人類生物年齡之的通用多重因素方案。
公司表示,此次收購將讓集團得以擴展至2017年估計價值超過4.2萬億美元的全球保健市場。此外,大眾對長壽市場的興趣與日俱增,DLI希望於旗下包括2019冠狀病毒病關聯項目(流行病學研究顯示年齡是影響2019冠狀病毒病疾病嚴重程度最重要因素之一)在內的應用中佔據領先優勢。DLI深層血液學時鐘可作為分析2019冠狀病毒病陽性患者的檢測工具。因此本集團相信,於目前發展階段收購DLI可受惠於巨大增長潛力,而更重要的是,集團相信收購事項的條款對股東具有吸引力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.